Functional Outcomes After Injections of Platelet-Rich Plasma for Plantar Fasciitis.

Objective Plantar fasciitis is a rather common disorder with symptoms like heel discomfort. It usually gets worse with prolonged rest. Platelet-rich plasma (PRP) injections, derived from autologous blood, have emerged as a promising treatment option by promoting tissue healing and reducing inflammation. This study evaluates the outcome of PRP injections in decreasing pain and improving patients' function. Methods This study included 100 identified cases of plantar fasciitis altogether. After PRP injections, their results were evaluated using the American Orthopedic Foot and Ankle Score (AOFAS) at baseline and the visual analog scale (VAS) both at baseline and four, eight, and 12 weeks following injection. Results The mean VAS decreased to one from seven in males and from seven to one in females. A statistically significant difference existed between the males and females at four weeks (p ≤ 0.0001), eight weeks (p ≤ 0.0001), and 12 weeks (p = 1.0), and the AOFAS score reached 95/96 from 56/58 in males and females. Conclusion The efficacy of PRP in the treatment of plantar fasciitis is very high. It provides very good outcomes with significant pain relief while also promoting healing of the plantar fascia.